Osteoporosis Update: Many patients are on medication such as Zometa, Fosamax, Boniva, or Actonel to help treat and prevent osteoporosis. While these medications provide many benefits, they can also lead to side effects which affect your oral health. Healthcare providers and patients need to be aware of the signs, symptoms, and latest information regarding Medication-related Osteonecrosis of the Jaw (MRONJ).

Dana-Farber Cancer Center Guidelines
https://www.dana-farber.org/uploadedFiles/Pages/For_Patients_and_Families/Care_and_Treatment/Treatment_Centers/Oral_Medicine_and_Dentistry/dental-mronj.pdf

Dental Guidelines for Patients Who Have or are at Risk for Medication-Related Osteonecrosis of the Jaw (MRONJ)

Medication-related osteonecrosis of the jaw (MRONJ) is a condition in the mouth characterized by areas of necrotic maxillary and/or mandibular bone that is often associated with soft tissue infection and pain. MRONJ can be seen in patients receiving antiresorptive or antiangiogenic agents for cancer, osteoporosis, and metabolic and developmental bone diseases.